X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-11 | ARWR | Anzalone Christopher Richard | CEO | S - Sale+OE | $51.91 | -146,388 | 4,057,634 | -3% | -$7,598,864 | |||||
2022-01-05 | ARWR | O'Brien Patrick | GC | S - Sale | $61.72 | -32,500 | 348,075 | -9% | -$2,005,875 | ||||||
2022-01-05 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $61.70 | -40,000 | 464,005 | -8% | -$2,467,941 | ||||||
| M | 2022-01-04 | ARWR | Hamilton James C | Senior Vice President | S - Sale | $64.57 | -25,625 | 155,625 | -14% | -$1,654,591 | |||||
2022-01-03 | ARWR | Waddill William D. | Dir | S - Sale | $64.72 | -4,500 | 25,750 | -15% | -$291,244 | ||||||
2022-01-03 | ARWR | Olukotun Adeoye Y | Dir | S - Sale | $64.75 | -4,050 | 4,950 | -45% | -$262,233 | ||||||
2022-01-03 | ARWR | De Backer Marianne | Dir | S - Sale | $64.71 | -4,500 | 17,000 | -21% | -$291,177 | ||||||
2022-01-03 | ARWR | Perry Michael S | Dir | S - Sale | $64.71 | -4,500 | 85,500 | -5% | -$291,192 | ||||||
2021-12-28 | ARWR | Given Douglas B | Dir | P - Purchase | $66.37 | +655 | 136,243 | 0% | +$43,472 | ||||||
2021-12-28 | ARWR | Ferrari Mauro | Dir | S - Sale | $66.82 | -3,400 | 36,571 | -9% | -$227,188 | ||||||
2021-12-15 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $67.56 | -60,000 | 3,219,022 | -2% | -$4,053,431 | ||||||
2021-11-19 | ARWR | San Martin Javier | Chief Medical Officer | S - Sale | $69.31 | -19,500 | 111,000 | -15% | -$1,351,589 | ||||||
| M | 2021-10-20 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $65.77 | -65,000 | 3,279,022 | -2% | -$4,274,982 | |||||
2021-09-13 | ARWR | Olukotun Adeoye Y | Dir | S - Sale | $63.76 | -5,000 | 9,000 | -36% | -$318,800 | ||||||
2021-09-09 | ARWR | Given Douglas B | Dir | S - Sale | $65.24 | -5,000 | 136,243 | -4% | -$326,200 | ||||||
2021-06-24 | ARWR | De Backer Marianne | Dir | S - Sale | $89.85 | -5,000 | 21,500 | -19% | -$449,250 | ||||||
2021-06-22 | ARWR | Hassard James | Chief Commercial Officer | S - Sale | $89.22 | -3,625 | 105,750 | -3% | -$323,423 | ||||||
2021-06-22 | ARWR | Given Douglas B | Dir | S - Sale | $89.21 | -4,500 | 141,243 | -3% | -$401,445 | ||||||
2021-02-22 | ARWR | Given Douglas B | Dir | S - Sale | $88.73 | -1,125 | 145,743 | -1% | -$99,821 | ||||||
| D | 2021-02-08 | ARWR | O'Brien Patrick | GC | S - Sale+OE | $88.46 | -90,000 | 293,375 | -23% | -$7,961,240 | |||||
2021-01-15 | ARWR | Given Douglas B | Dir | S - Sale | $83.28 | -3,000 | 146,868 | -2% | -$249,840 | ||||||
2021-01-14 | ARWR | Hamilton James C | Senior Vice President | S - Sale | $81.29 | -10,000 | 126,250 | -7% | -$812,942 | ||||||
| M | 2021-01-11 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $81.02 | -13,038 | 444,005 | -3% | -$1,056,310 | |||||
2021-01-07 | ARWR | Hassard James | Chief Commercial Officer | S - Sale | $75.00 | -15,625 | 109,375 | -13% | -$1,171,875 | ||||||
2021-01-06 | ARWR | O'Brien Patrick | GC | S - Sale | $72.41 | -25,000 | 293,375 | -8% | -$1,810,346 | ||||||
2021-01-06 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $72.44 | -30,625 | 457,043 | -6% | -$2,218,477 | ||||||
| M | 2021-01-05 | ARWR | Hamilton James C | Senior Vice President | S - Sale | $72.51 | -38,750 | 136,250 | -22% | -$2,809,578 | |||||
2021-01-04 | ARWR | Perry Michael S | Dir | S - Sale | $76.09 | -4,000 | 184,000 | -2% | -$304,360 | ||||||
2021-01-04 | ARWR | Given Douglas B | Dir | S - Sale | $76.08 | -4,000 | 119,368 | -3% | -$304,320 | ||||||
2021-01-04 | ARWR | Waddill William D. | Dir | S - Sale | $76.08 | -3,750 | 30,250 | -11% | -$285,300 | ||||||
2020-12-17 | ARWR | Given Douglas B | Dir | S - Sale | $79.32 | -9,575 | 129,738 | -7% | -$759,443 | ||||||
2020-12-10 | ARWR | Waddill William D. | Dir | S - Sale | $71.26 | -3,000 | 25,000 | -11% | -$213,780 | ||||||
| DM | 2020-12-08 | ARWR | Anzalone Christopher Richard | CEO | S - Sale+OE | $68.73 | -55,000 | 2,505,237 | -2% | -$3,780,347 | |||||
| M | 2020-11-19 | ARWR | Bradshaw Curt | Chief Scientific Officer | S - Sale | $69.06 | -31,250 | 0 | -100% | -$2,158,125 | |||||
2020-11-19 | ARWR | San Martin Javier | Chief Medical Officer | S - Sale | $69.39 | -19,500 | 130,500 | -13% | -$1,353,105 | ||||||
| D | 2020-11-09 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $69.37 | -43,505 | 427,668 | -9% | -$3,018,071 | |||||
2020-10-08 | ARWR | De Backer Marianne | Dir | P - Purchase | $50.47 | +1,000 | 17,500 | +6% | +$50,465 | ||||||
2020-10-23 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $58.21 | -100,000 | 2,505,237 | -4% | -$5,821,032 | ||||||
| D | 2020-10-20 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $54.04 | -29,166 | 427,668 | -6% | -$1,576,131 | |||||
2020-10-09 | ARWR | Ferrari Mauro | Dir | S - Sale | $48.00 | -10,000 | 30,971 | -24% | -$480,000 | ||||||
| D | 2020-08-13 | ARWR | Anzalone Christopher Richard | CEO | S - Sale+OE | $41.35 | -50,000 | 2,605,237 | -2% | -$2,067,500 | |||||
2020-06-25 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $38.81 | -100,000 | 2,605,237 | -4% | -$3,881,017 | ||||||
| M | 2020-01-13 | ARWR | De Backer Marianne | Dir | P - Purchase | $33.56 | +4,000 | 16,500 | +32% | +$134,240 | |||||
2020-05-12 | ARWR | Perry Michael S | Dir | S - Sale | $35.83 | -36,000 | 8,000 | -82% | -$1,289,891 | ||||||
2020-05-11 | ARWR | Waddill William D. | Dir | S - Sale | $36.54 | -26,000 | 28,000 | -48% | -$950,040 | ||||||
| DM | 2020-04-27 | ARWR | Given Bruce D | COO | S - Sale+OE | $40.00 | -5,401 | 850,730 | -1% | -$216,040 | |||||
| D | 2020-04-20 | ARWR | Given Bruce D | COO | S - Sale+OE | $40.00 | -23,515 | 851,734 | -3% | -$940,600 | |||||
2020-04-14 | ARWR | Given Douglas B | Dir | S - Sale | $36.89 | -25,000 | 154,813 | -14% | -$922,250 | ||||||
| D | 2020-01-21 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $49.44 | -40,313 | 384,223 | -9% | -$1,992,925 | |||||
2020-01-06 | ARWR | Given Bruce D | COO | S - Sale | $60.13 | -35,613 | 858,993 | -4% | -$2,141,285 | ||||||
2020-01-06 | ARWR | O'Brien Patrick | GC | S - Sale | $60.12 | -14,625 | 258,375 | -5% | -$879,261 | ||||||
2020-01-06 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $60.11 | -20,000 | 391,185 | -5% | -$1,202,201 | ||||||
2019-12-24 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $63.50 | -83,333 | 1,805,237 | -4% | -$5,291,646 | ||||||
| M | 2019-12-12 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $67.15 | -183,333 | 1,888,570 | -9% | -$12,310,119 | |||||
| M | 2019-12-02 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $67.33 | -50,000 | 2,071,903 | -2% | -$3,366,522 | |||||
| D | 2019-11-01 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $40.85 | -37,884 | 313,536 | -11% | -$1,547,378 | |||||
| D | 2019-10-10 | ARWR | Anzalone Christopher Richard | CEO | S - Sale+OE | $31.83 | -56,325 | 2,121,903 | -3% | -$1,792,825 | |||||
2019-09-25 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $28.25 | -20,000 | 2,121,903 | -1% | -$565,000 | ||||||
| DM | 2019-09-20 | ARWR | Anzalone Christopher Richard | CEO | S - Sale+OE | $28.54 | -112,650 | 2,141,903 | -5% | -$3,215,055 | |||||
| M | 2019-09-09 | ARWR | Perry Michael S | Dir | S - Sale | $29.41 | -185,000 | 36,000 | -84% | -$5,440,000 | |||||
2019-06-26 | ARWR | Ferrari Mauro | Dir | S - Sale | $27.61 | -17,756 | 1,900 | -90% | -$490,243 | ||||||
2019-05-28 | ARWR | O'Brien Patrick | GC | S - Sale | $24.88 | -30,000 | 203,000 | -13% | -$746,400 | ||||||
2019-05-21 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $22.00 | -27,071 | 278,536 | -9% | -$595,562 | ||||||
2019-04-03 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $19.30 | -50,000 | 2,092,455 | -2% | -$965,000 | ||||||
| D | 2019-03-01 | ARWR | Given Bruce D | COO | S - Sale+OE | $19.99 | -42,500 | 644,606 | -6% | -$849,575 | |||||
| D | 2019-02-25 | ARWR | Given Bruce D | COO | S - Sale+OE | $18.98 | -42,500 | 644,606 | -6% | -$806,650 | |||||
| D | 2019-02-19 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $18.00 | -8,000 | 305,607 | -3% | -$144,000 | |||||
| DM | 2019-02-15 | ARWR | Given Bruce D | COO | S - Sale+OE | $17.86 | -68,750 | 644,606 | -10% | -$1,227,988 | |||||
| DM | 2019-02-08 | ARWR | Given Bruce D | COO | S - Sale+OE | $16.04 | -242,834 | 670,856 | -27% | -$3,894,247 | |||||
2019-02-05 | ARWR | Given Bruce D | COO | S - Sale | $14.48 | -22,500 | 847,856 | -3% | -$325,800 | ||||||
2019-02-01 | ARWR | Given Bruce D | COO | S - Sale | $13.85 | -28,500 | 870,356 | -3% | -$394,725 | ||||||
| M | 2019-01-22 | ARWR | Given Bruce D | COO | S - Sale | $13.54 | -169,500 | 898,856 | -16% | -$2,295,805 | |||||
2019-01-22 | ARWR | Given Douglas B | Dir | S - Sale | $13.58 | -3,000 | 178,130 | -2% | -$40,740 | ||||||
2019-01-18 | ARWR | O'Brien Patrick | GC | S - Sale | $14.43 | -72,000 | 233,000 | -24% | -$1,038,960 | ||||||
2019-01-17 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $14.55 | -81,875 | 305,607 | -21% | -$1,191,281 | ||||||
2019-01-14 | ARWR | Li Zhen | Snr. VP, Chem, Non-Clin Dev | S - Sale | $14.34 | -40,500 | 201,700 | -17% | -$580,770 | ||||||
| D | 2019-01-14 | ARWR | Given Bruce D | COO | S - Sale+OE | $14.40 | -42,666 | 1,068,356 | -4% | -$614,390 | |||||
2019-01-11 | ARWR | Waddill William D. | Dir | S - Sale | $14.77 | -8,500 | 46,500 | -15% | -$125,545 | ||||||
2019-01-02 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $11.98 | -8,333 | 387,482 | -2% | -$99,829 | ||||||
2019-01-02 | ARWR | Given Bruce D | COO | S - Sale | $11.98 | -20,000 | 1,098,356 | -2% | -$239,600 | ||||||
2018-12-27 | ARWR | Given Douglas B | Dir | S - Sale | $12.00 | -3,000 | 145,130 | -2% | -$36,000 | ||||||
2018-12-19 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $13.92 | -90,000 | 1,542,455 | -6% | -$1,252,800 | ||||||
2018-12-12 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $14.07 | -90,000 | 1,632,455 | -5% | -$1,266,300 | ||||||
2018-11-23 | ARWR | Given Douglas B | Dir | S - Sale | $12.74 | -3,000 | 148,130 | -2% | -$38,220 | ||||||
2018-11-09 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $14.39 | -81,500 | 1,722,455 | -5% | -$1,172,705 | ||||||
| D | 2018-10-19 | ARWR | Leone Peter Brian | VP, Strategic Bus. Initiatives | S - Sale+OE | $13.49 | -131,137 | 130,000 | -50% | -$1,769,038 | |||||
| D | 2018-09-06 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $19.34 | -45,000 | 310,815 | -13% | -$870,200 | |||||
| M | 2018-08-31 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $14.45 | -164,834 | 1,803,955 | -8% | -$2,381,851 | |||||
| D | 2018-06-19 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $14.01 | -20,000 | 310,815 | -6% | -$280,200 | |||||
| DM | 2018-05-30 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $11.00 | -14,000 | 310,815 | -4% | -$154,000 | |||||
2018-04-24 | ARWR | Given Douglas B | Dir | S - Sale | $6.63 | -25,000 | 155,000 | -14% | -$165,750 | ||||||
| D | 2018-03-27 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $8.00 | -20,000 | 310,815 | -6% | -$160,000 | |||||
2018-03-16 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $7.40 | -26,000 | 1,968,789 | -1% | -$192,400 | ||||||
| M | 2018-03-13 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $7.43 | -300,000 | 1,994,789 | -13% | -$2,228,000 | |||||
2018-03-05 | ARWR | Given Bruce D | COO | S - Sale | $6.73 | -20,000 | 908,356 | -2% | -$134,600 | ||||||
2018-01-01 | ARWR | Given Bruce D | COO | S - Sale | $3.69 | -20,000 | 928,356 | -2% | -$73,800 | ||||||
2016-10-14 | ARWR | Given Douglas B | Dir | S - Sale | $6.72 | -12,000 | 70,000 | -15% | -$80,640 | 0 | -1 | -29 | -78 | ||
| ADM | 2016-08-22 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $8.00 | -20,000 | 115,689 | -15% | -$160,000 | -1 | +2 | +1 | -67 | |
| DM | 2016-08-22 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $8.00 | -20,000 | 115,689 | -15% | -$160,000 | 0 | +2 | +4 | -59 | |
| D | 2015-12-30 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale+OE | $6.13 | -23,347 | 135,000 | -15% | -$143,117 | -2 | -10 | -44 | -8 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |